End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.33 USD | -16.01% |
|
-2.22% | -98.78% |
05-21 | Earnings Flash (SBFM) SUNSHINE BIOPHARMA Posts Q1 Revenue $7.5M | MT |
05-20 | Sunshine Biopharma, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Sales 2024 * | 44.94M 61.61M | Sales 2025 * | 100M 137M | Capitalization | 7.4M 10.15M |
---|---|---|---|---|---|
Net income 2024 * | - 0 | Net income 2025 * | 11M 15.08M | EV / Sales 2024 * | 0.16 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 0.07 x |
P/E ratio 2024 * |
-0.39
x | P/E ratio 2025 * |
0.01
x | Employees | 44 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.5% |
1 day | -16.01% | ||
1 week | -2.22% | ||
Current month | -47.33% | ||
1 month | -64.52% | ||
3 months | -93.83% | ||
6 months | -98.67% | ||
Current year | -98.78% |
![Extreme 0.282](/images/extremecours_fleche.png)
![Extreme 0.2811](/images/extremecours_fleche.png)
![Extreme 0.2811](/images/extremecours_fleche.png)
![Extreme 0.2811](/images/extremecours_fleche.png)
![Extreme 0.2811](/images/extremecours_fleche.png)
![Extreme 0.2811](/images/extremecours_fleche.png)
![Extreme 0.2811](/images/extremecours_fleche.png)
Managers | Title | Age | Since |
---|---|---|---|
Steve Slilaty
CEO | Chief Executive Officer | 71 | 09-10-14 |
Camille Sebaaly
DFI | Director of Finance/CFO | 62 | 09-10-14 |
Marc Beaudoin
COO | Chief Operating Officer | - | 01-24 |
Members of the board | Title | Age | Since |
---|---|---|---|
David Natan
BRD | Director/Board Member | 70 | 22-01-31 |
Steve Slilaty
CEO | Chief Executive Officer | 71 | 09-10-14 |
Camille Sebaaly
DFI | Director of Finance/CFO | 62 | 09-10-14 |
Date | Price | Change | Volume |
---|---|---|---|
24-06-18 | 0.3908 | +28.89% | 8,604,018 |
24-06-17 | 0.3032 | -8.12% | 1,753,257 |
24-06-14 | 0.33 | -16.01% | 3,708,382 |
24-06-13 | 0.3929 | +37.76% | 23,458,339 |
24-06-12 | 0.2852 | -15.50% | 3,798,658 |
End-of-day quote Nasdaq, June 13, 2024
More quotes![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-98.78% | 7.4M | |
+52.93% | 803B | |
+40.98% | 629B | |
-7.08% | 351B | |
+17.40% | 324B | |
+10.58% | 303B | |
+16.42% | 244B | |
+2.17% | 226B | |
+10.66% | 215B | |
+6.24% | 164B |
- Stock Market
- Equities
- SBFM Stock